Rui Ling

1.7k total citations
63 papers, 1.1k citations indexed

About

Rui Ling is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rui Ling has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 25 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Rui Ling's work include Breast Cancer Treatment Studies (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Epigenetics and DNA Methylation (8 papers). Rui Ling is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Epigenetics and DNA Methylation (8 papers). Rui Ling collaborates with scholars based in China, Japan and Singapore. Rui Ling's co-authors include Jianghao Chen, Jun Yun, Hui Wang, Juliang Zhang, Ying Wu, Shifang Yuan, Zhe Wang, Xiaojun Li, Ling Wang and Lina Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Rui Ling

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Ling China 18 638 395 236 129 100 63 1.1k
Jing Yuan China 21 884 1.4× 347 0.9× 331 1.4× 182 1.4× 87 0.9× 51 1.4k
Adriane Feijó Evangelista Brazil 22 834 1.3× 622 1.6× 265 1.1× 128 1.0× 148 1.5× 75 1.4k
Hyunho Yoon South Korea 16 569 0.9× 277 0.7× 365 1.5× 111 0.9× 123 1.2× 30 1.1k
Yulin Sun China 20 649 1.0× 375 0.9× 231 1.0× 163 1.3× 84 0.8× 56 1.0k
Cuiling Qi China 19 545 0.9× 296 0.7× 346 1.5× 134 1.0× 163 1.6× 44 1.1k
Guo‐Hui Fu China 22 801 1.3× 443 1.1× 298 1.3× 128 1.0× 122 1.2× 64 1.4k
Xin Lin China 19 668 1.0× 339 0.9× 163 0.7× 106 0.8× 165 1.6× 51 1.1k
Kui Sheng Chen China 2 606 0.9× 241 0.6× 216 0.9× 144 1.1× 97 1.0× 5 1.0k

Countries citing papers authored by Rui Ling

Since Specialization
Citations

This map shows the geographic impact of Rui Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Ling more than expected).

Fields of papers citing papers by Rui Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Ling. The network helps show where Rui Ling may publish in the future.

Co-authorship network of co-authors of Rui Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Ling. A scholar is included among the top collaborators of Rui Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Ling. Rui Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, Rui, et al.. (2025). Dual-Frequency Power Amplifiers’ Design Based on Improved Multiobjective Particle Swarm Optimization Algorithm. IEEE Microwave and Wireless Technology Letters. 35(11). 1768–1771. 1 indexed citations
2.
Wang, Zhe, et al.. (2025). Leaf-vein-inspired multi-organ microfluidic chip for modeling breast cancer CTC organotropism. Frontiers in Oncology. 15. 1602225–1602225.
3.
Huang, Meiling, et al.. (2025). KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog signaling pathway. Breast Cancer. 32(5). 1088–1101.
4.
Wang, Jiajia, Peng Shen, Cong Fan, et al.. (2024). XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer. Cancer Letters. 596. 216846–216846. 18 indexed citations
5.
Wang, Yunchuan, Kuo Shen, Tao Ke, et al.. (2024). Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA). Diabetes/Metabolism Research and Reviews. 40(3). e3776–e3776. 14 indexed citations
6.
Huynh, Nam Cong‐Nhat, Rui Ling, Tianshu Shi, et al.. (2024). Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis. Inflammation and Regeneration. 44(1). 36–36. 4 indexed citations
7.
Ling, Rui, et al.. (2023). Comprehensive analysis of CDK5 as a novel biomarker for progression in esophageal cancer. Esophagus. 20(3). 502–514. 1 indexed citations
8.
Komatsu, Noriko, Rui Ling, Kazuo Okamoto, et al.. (2023). Effect of JAK inhibitors on the three forms of bone damage in autoimmune arthritis: joint erosion, periarticular osteopenia, and systemic bone loss. Inflammation and Regeneration. 43(1). 44–44. 8 indexed citations
9.
10.
11.
12.
Yu, Zhiwei, Yi Wan, Jing Fan, et al.. (2021). Iodine intake level and incidence of thyroid disease in adults in Shaanxi province: a cross-sectional study. Annals of Translational Medicine. 9(20). 1567–1567. 10 indexed citations
13.
Li, Lun, Benlong Yang, Hongyuan Li, et al.. (2019). Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol. BMJ Open. 9(12). e032945–e032945. 9 indexed citations
14.
Yuqing, Yang, Lei Wang, Jingjing Xiao, et al.. (2019). Clinical significance of 21-gene recurrence score assay for hormone receptor–positive, lymph node-negative breast cancer in early stage. Experimental and Molecular Pathology. 108. 150–155. 4 indexed citations
15.
Zhang, Jing, Yibing Chen, Xiaoying Ji, et al.. (2018). Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells. Cell Death and Disease. 9(11). 1050–1050. 56 indexed citations
16.
Yun, Jun, Jun Ho Yi, Xin Li, et al.. (2017). [TNF-α regulates the proliferation of human breast cancer cells via regulation of ceramide content].. PubMed. 33(10). 1303–1309. 3 indexed citations
17.
Wang, Zhe, Jing Kong, Ying Wu, et al.. (2017). PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer. Breast Cancer Research and Treatment. 168(2). 531–542. 44 indexed citations
18.
Yao, Qin, Juxiang Chen, Yan Wang, et al.. (2015). Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer. Genetics and Molecular Research. 14(1). 2099–2103. 7 indexed citations
19.
Wang, Hui, Lei Wang, Zheng Wu, et al.. (2014). Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. Medical Oncology. 31(12). 298–298. 61 indexed citations
20.
Wang, Hui, Nanlin Li, Haifeng Jin, et al.. (2013). Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma. Phytomedicine. 20(11). 985–991. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Yuan Breakdown of academic impact, for papers by Adriane Feijó Evangelista Breakdown of academic impact, for papers by Hyunho Yoon Breakdown of academic impact, for papers by Yulin Sun Breakdown of academic impact, for papers by Cuiling Qi Breakdown of academic impact, for papers by Guo‐Hui Fu Breakdown of academic impact, for papers by Xin Lin Breakdown of academic impact, for papers by Kui Sheng Chen
Rankless by CCL
2026